AC Immune SA (IMR.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
As of 07:02PM CEST. Market open.
| Previous close | 2.1550 |
| Open | 2.1450 |
| Bid | 2.1700 x 0 |
| Ask | 2.2850 x 0 |
| Day's range | 2.1450 - 2.2950 |
| 52-week range | 1.7080 - 4.5000 |
| Volume | |
| Avg. volume | 894 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
We Think AC Immune (NASDAQ:ACIU) Can Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although...
- Simply Wall St.
Further weakness as AC Immune (NASDAQ:ACIU) drops 12% this week, taking three-year losses to 58%
AC Immune SA ( NASDAQ:ACIU ) shareholders should be happy to see the share price up 17% in the last month. But over the...
- Zacks
AbbVie (ABBV) Announces Appointment of New CEO Robert Michael
Robert Michael is set to succeed Richard A. Gonzalez as AbbVie's (ABBV) CEO, effective Jul 1, 2024.
© 2024 Yahoo. All rights reserved.